Tectonic Therapeutic (TECX) Interest Expenses (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Interest Expenses of $28.7 million for Q1 2026, up 18895.36% year-over-year from N/an in Q1 2025, and up 238925.0% quarter-over-quarter from $12000.0 in Q4 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Interest Expenses (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Interest Expenses for 10 consecutive years, with $28.7 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Expenses rose 18895.36% year-over-year to $28.7 million; the TTM figure through Mar 2026 stood at $28.7 million (up 18895.36% YoY), while the FY2025 annual figure was $188.9 million, up 11.0% from the prior year.
- Interest Expenses climbed to $28.7 million in Q1 2026 per TECX's latest filing, from $12000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $33.5 million in Q3 2024 and bottomed at $12000.0 in Q4 2025.
- Historically, Interest Expenses has averaged $5.0 million across 5 years, with a median of $994000.0 in 2023.
- Annual changes were most pronounced in 2025 — Interest Expenses tumbled 99.83% — and 2026, when it jumped 18895.36%.
- Tectonic Therapeutic's Interest Expenses stood at $806000.0 in 2022, then sank by 95.78% to $34000.0 in 2023, then tumbled by 35.29% to $22000.0 in 2024, then sank by 45.45% to $12000.0 in 2025, then surged by 238925.0% to $28.7 million in 2026.
- Business Quant data shows TECX's Interest Expenses at $28.7 million in Q1 2026, $12000.0 in Q4 2025, and $5.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Tectonic Therapeutic | 582.76 Mn | 582.76 Mn | - | 6,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Dec 31, 2025 | 12,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 17,000.00 |
| Mar 31, 2025 | 20,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Jun 30, 2023 | 40,000.00 |
| Mar 31, 2022 | 45,000.00 |
| Jun 30, 2021 | 21,000.00 |
| Mar 31, 2021 | 25,000.00 |
| Dec 31, 2020 | 80,000.00 |
| Sep 30, 2020 | 74,000.00 |
| Jun 30, 2020 | 33,000.00 |
| Mar 31, 2020 | 16,000.00 |